Efficacy and Safety Outcomes of Intravitreal Dexamethasone Implant Therapy for the Treatment of Adult Coats’ Disease

Efficacy and Safety Outcomes of Intravitreal Dexamethasone Implant Therapy for the Treatment of Adult Coats’ Disease

Purpose. To evaluate the efficacy and safety outcomes of dexamethasone intravitreal implant in patients with Stage 3A Coats’ disease. Methods. A consecutive case series of adult Coats’ disease managed with or without intravitreal dexamethasone implant (Ozurdex®, Allergan Inc., Irvine, California, US...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qingshan Chen, Saying Liang, Xizhen Wang, Chenli Hu, Jieting She, Zi Li
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2020/9131908
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)
by: Erdem Eris, et al.
Published: (2017-01-01)

The Efficacy and Safety of Dexamethasone Intravitreal Implant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis of Randomized Controlled Trials
by: Li Xiaodong, et al.
Published: (2022-01-01)

Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes
by: Sigrid Freissinger, et al.
Published: (2020-01-01)

Intravitreal dexamethasone implant (Ozurdex®) findings over time: ultrasound and ultra-widefield fundus photography
by: Gabriela Assumpção Brito Pereira Pellegrini, et al.
Published: (2025-01-01)

Switch of Intravitreal Therapy for Macular Edema Secondary to Retinal Vein Occlusion from Anti-VEGF to Dexamethasone Implant and Vice Versa
by: Amelie Pielen, et al.
Published: (2017-01-01)

Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
by: Mohamed Loutfi, et al.
Published: (2014-01-01)

Location of a Dexamethasone Implant at the Macula after Intravitreal Injection in a Silicone Oil-Filled Eye
by: Cenap Mahmut Esenulku, et al.
Published: (2016-01-01)

Intravitreal Clindamycin and Dexamethasone Combined with Systemic Oral Antitoxoplasma Therapy versus Intravitreal Therapy Alone in the Management of Toxoplasma Retinochoroiditis: A Retrospective Study
by: Ashraf Bor’i, et al.
Published: (2018-01-01)

Twelve-Month Outcomes and Optical Coherence Tomography (OCT) Biomarkers After Intravitreal Dexamethasone Implantation in Pseudophakic Eyes with Post-Vitrectomy Cystoid Macular Edema (CME)—Refractory to Medical Therapy
by: Francesco Pignatelli, et al.
Published: (2025-01-01)

Intravitreal Dexamethasone in the Management of Delayed-Onset Bleb-Associated Endophthalmitis
by: David J. Jacobs, et al.
Published: (2012-01-01)

Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis
by: Xiaolei Sun, et al.
Published: (2020-01-01)

Concomitant Intravitreal Ganciclovir and Dexamethasone Therapy in the Management of Acute Retinal Necrosis in a Patient Previously Treated with Oral Famciclovir
by: Chirag V. Patel, et al.
Published: (2017-01-01)

Association between Hyperreflective Foci on Spectral-Domain Optical Coherence Tomography and Early Recurrence of Diabetic Macular Edema after Intravitreal Dexamethasone Implantation
by: Kyung Tae Kim, et al.
Published: (2019-01-01)

Comparative Outcomes of Standard Perioperative Eye Drops, Intravitreal Triamcinolone Acetonide-Moxifloxacin, and Intracameral Dexamethasone-Moxifloxacin-Ketorolac in Cataract Surgery
by: Robin K. Kuriakose, et al.
Published: (2022-01-01)

Morphological and Functional Outcomes after Intravitreal Dexamethasone Injection for Macular Edema in Patients with Central Vein Occlusion at 48-Week Follow-Up
by: Cristina Nicula, et al.
Published: (2020-01-01)

Surgical Management of Complications after Dexamethasone Implant
by: Giancarlo Sborgia, et al.
Published: (2020-01-01)

Splitting of a Dexamethasone Implant (Ozurdex) following the Injection
by: Oya Donmez, et al.
Published: (2013-01-01)

Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy
by: Jinglin Cui, et al.
Published: (2018-01-01)

Intravitreal Dexamethasone in Patients with Wet Age-Related Macular Degeneration Resistant to Anti-VEGF: A Prospective Pilot Study
by: Ermete Giancipoli, et al.
Published: (2018-01-01)

Enhancing stone expulsion: The efficacy of combined medical therapy with tamsulosin and dexamethasone in renal colic patients
by: Reza Kazemi, et al.
Published: (2025-01-01)

The Efficacy of Intravitreal Conbercept for Chronic Central Serous Chorioretinopathy
by: Jianbo Mao, et al.
Published: (2019-01-01)

Intravitreal Therapy for Diabetic Macular Edema: An Update
by: Claudio Furino, et al.
Published: (2021-01-01)

Atomized Neutrophil Membrane-coated MOF Nanoparticles for Direct Delivery of Dexamethasone for Severe Pneumonia
by: Yixiao Yang, et al.
Published: (2025-01-01)

Favorable Outcome of Ramsay Hunt Syndrome under Dexamethasone
by: Josef Finsterer, et al.
Published: (2012-01-01)

Efficacy and safety of dexamethasone or triamcinolone in combination with anti-vascular endothelial growth factor therapy for diabetic macular edema: A systematic review and meta-analysis with trial sequential analysis.
by: Bo Zhou, et al.
Published: (2025-01-01)

The effectiveness of dexamethasone as a combination therapy for COVID-19
by: Namazi Nader
Published: (2022-09-01)

Behavior of SD-OCT Detectable Hyperreflective Foci in Diabetic Macular Edema Patients after Therapy with Anti-VEGF Agents and Dexamethasone Implants
by: Anne Rübsam, et al.
Published: (2021-01-01)

Cochlear implantation outcomes in adults: A scoping review.
by: Isabelle Boisvert, et al.
Published: (2020-01-01)

“Magic Bullet”: Eccentric Macular Hole as a Complication from Dexamethasone Implant Insertion
by: Logan Christensen, et al.
Published: (2016-01-01)

Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis
by: Yi Xu, et al.
Published: (2021-01-01)

Efficacy of Carfilzomib, Lenalidomide, and Dexamethasone for Extramedullary Intracranial Localization of Multiple Myeloma
by: Giuseppe Mele, et al.
Published: (2018-01-01)

Fluoride Coatings on Magnesium Alloy Implants
by: ChuanYao Zhai, et al.
Published: (2022-01-01)

Five-Month Observation of Persistent Diabetic Macular Edema after Intravitreal Injection of Ozurdex Implant
by: Dominik Zalewski, et al.
Published: (2014-01-01)

Use and Outcomes of Dexamethasone in the Management of Malignant Small Bowel Obstruction
by: Frank F. Yang, MD, et al.
Published: (2024-06-01)

Intra-operative Intravitreal Bevacizumab For Patients With Diabetic Macular Edema Undergoing Phacoemulsification with Foldable IOL Implantation
by: Haider Ali Chaudhry, et al.
Published: (2024-06-01)

Evaluation of Peripapillary Nerve Fiber Layer after Dexamethasone Implantation (Ozurdex) in Branch Retinal Vein Occlusions
by: Muhammed Nurullah Bulut, et al.
Published: (2016-01-01)

Efficacy Comparison of Intravitreal Anti-VEGF Therapy for Three Subtypes of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
by: Jianqing Li, et al.
Published: (2018-01-01)

Effect of Preoperative Intravitreal Bevacizumab on the Surgical Outcome of Neovascular Glaucoma at Different Stages
by: Junki Kwon, et al.
Published: (2017-01-01)

In vivo reduction of biofilm seeded on orthopaedic implants: safety and efficacy of portable electromagnetic induction heating
by: Enrique Cordero García-Galán, et al.
Published: (2024-12-01)

Astroglial Plasticity Is Implicated in Hippocampal Remodelling in Adult Rats Exposed to Antenatal Dexamethasone
by: Vishvesh H. Shende, et al.
Published: (2015-01-01)